GLAND PHARMA
Back to Balance Sheet
|
GLAND PHARMA Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹4,390 Cr | ₹4,966 Cr | ₹1,877 Cr | ₹1,982 Cr | ₹1,372 Cr |
What is the latest Total Non-Current Assets ratio of GLAND PHARMA ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹4,390 Cr |
| Mar2024 | ₹4,966 Cr |
| Mar2023 | ₹1,877 Cr |
| Mar2022 | ₹1,982 Cr |
| Mar2021 | ₹1,372 Cr |
How is Total Non-Current Assets of GLAND PHARMA Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹4,390 Cr | -11.59 | |
| Mar2024 | ₹4,966 Cr | 164.59 | |
| Mar2023 | ₹1,877 Cr | -5.29 | |
| Mar2022 | ₹1,982 Cr | 44.38 | |
| Mar2021 | ₹1,372 Cr | - | |
Compare Total Non-Current Assets of peers of GLAND PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLAND PHARMA | ₹30,043.0 Cr | 1.1% | -1.2% | 22.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹417,028.0 Cr | 0.3% | 9% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,237.0 Cr | 1.9% | 5.9% | 12.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,801.0 Cr | 0.6% | 9.5% | 45% | Stock Analytics | |
| CIPLA | ₹108,861.0 Cr | 1.6% | 1.8% | -7.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,435.0 Cr | -1.5% | 5.7% | 14.5% | Stock Analytics | |
GLAND PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLAND PHARMA | 1.1% |
-1.2% |
22.5% |
| SENSEX | -1.8% |
-1.6% |
7.3% |
You may also like the below Video Courses